GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $458,000 | +7.8% | 10,399 | -6.5% | 0.12% | -0.9% |
| Q3 2021 | $425,000 | -37.4% | 11,117 | -34.7% | 0.12% | -38.9% |
| Q2 2021 | $679,000 | -79.7% | 17,036 | -81.8% | 0.19% | -80.8% |
| Q1 2021 | $3,346,000 | -34.6% | 93,762 | -32.6% | 0.99% | -38.4% |
| Q4 2020 | $5,116,000 | +0.4% | 139,025 | +2.7% | 1.61% | -14.4% |
| Q3 2020 | $5,094,000 | -9.5% | 135,340 | -1.9% | 1.88% | -12.1% |
| Q2 2020 | $5,627,000 | -2.7% | 137,947 | -9.7% | 2.14% | +8.5% |
| Q1 2020 | $5,786,000 | -9.5% | 152,689 | +12.2% | 1.97% | +18.7% |
| Q4 2019 | $6,394,000 | -2.5% | 136,074 | -11.5% | 1.66% | -12.5% |
| Q3 2019 | $6,560,000 | +9.0% | 153,696 | +2.2% | 1.90% | -7.8% |
| Q2 2019 | $6,021,000 | -0.4% | 150,442 | +4.0% | 2.06% | -0.0% |
| Q1 2019 | $6,047,000 | +13.3% | 144,704 | +3.6% | 2.06% | +1.8% |
| Q4 2018 | $5,337,000 | -0.9% | 139,650 | +4.2% | 2.02% | +10.1% |
| Q3 2018 | $5,384,000 | -0.4% | 134,030 | -0.0% | 1.84% | -5.0% |
| Q2 2018 | $5,404,000 | +5.6% | 134,077 | +2.4% | 1.93% | -3.7% |
| Q1 2018 | $5,118,000 | +15.6% | 130,987 | +4.9% | 2.01% | +16.9% |
| Q4 2017 | $4,429,000 | -8.2% | 124,866 | +5.1% | 1.72% | -13.0% |
| Q3 2017 | $4,822,000 | -0.1% | 118,766 | +6.1% | 1.98% | -6.9% |
| Q2 2017 | $4,829,000 | +10.1% | 111,974 | +7.6% | 2.12% | +7.7% |
| Q1 2017 | $4,387,000 | +10.4% | 104,045 | +0.9% | 1.97% | +5.2% |
| Q4 2016 | $3,973,000 | -10.3% | 103,157 | +0.5% | 1.87% | -10.4% |
| Q3 2016 | $4,427,000 | +0.6% | 102,654 | +1.1% | 2.09% | -3.7% |
| Q2 2016 | $4,402,000 | +5.1% | 101,574 | -1.7% | 2.17% | +5.8% |
| Q1 2016 | $4,189,000 | -1.2% | 103,312 | -1.7% | 2.05% | -1.2% |
| Q4 2015 | $4,239,000 | +6.5% | 105,048 | +1.5% | 2.08% | +5.1% |
| Q3 2015 | $3,980,000 | -4.6% | 103,518 | +3.4% | 1.98% | -0.6% |
| Q2 2015 | $4,170,000 | -6.7% | 100,130 | +3.4% | 1.99% | -5.3% |
| Q1 2015 | $4,468,000 | +12.7% | 96,828 | +4.4% | 2.10% | +15.0% |
| Q4 2014 | $3,964,000 | -5.1% | 92,753 | +2.1% | 1.82% | -11.7% |
| Q3 2014 | $4,178,000 | -12.2% | 90,889 | +2.2% | 2.07% | -12.3% |
| Q2 2014 | $4,756,000 | +2.9% | 88,930 | +2.8% | 2.36% | +3.6% |
| Q1 2014 | $4,621,000 | -0.6% | 86,485 | -0.7% | 2.28% | -9.6% |
| Q4 2013 | $4,651,000 | +6.9% | 87,108 | +0.5% | 2.52% | +3.8% |
| Q3 2013 | $4,350,000 | +1.9% | 86,703 | +1.5% | 2.43% | -4.4% |
| Q2 2013 | $4,267,000 | – | 85,400 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |